These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33058141)

  • 61. Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation.
    Alvarez-Salazar EK; Cortés-Hernández A; Arteaga-Cruz S; Alberú-Gómez J; Soldevila G
    Front Immunol; 2020; 11():375. PubMed ID: 32300340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.
    Ahmadi T; Flies A; Efebera Y; Sherr DH
    Immunology; 2008 May; 124(1):129-40. PubMed ID: 18067555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expansion of human regulatory T-cells from patients with type 1 diabetes.
    Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
    Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lenalidomide potentiates CD4
    Grygorowicz MA; Borycka IS; Nowak E; Paszkiewicz-Kozik E; Rymkiewicz G; Błachnio K; Biernacka M; Bujko M; Walewski J; Markowicz S
    Clin Exp Med; 2017 May; 17(2):193-207. PubMed ID: 26961690
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.
    Veerapathran A; Pidala J; Beato F; Yu XZ; Anasetti C
    Blood; 2011 Nov; 118(20):5671-80. PubMed ID: 21948174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell enrichment-free massive ex-vivo expansion of peripheral CD20⁺ B cells via CD40-CD40L signals in non-human primates.
    Kim JS; Byun N; Chung H; Kim HJ; Kim JM; Chun T; Lee WW; Park CG
    Biochem Biophys Res Commun; 2016 Apr; 473(1):92-98. PubMed ID: 26993166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
    McClymont SA; Putnam AL; Lee MR; Esensten JH; Liu W; Hulme MA; Hoffmüller U; Baron U; Olek S; Bluestone JA; Brusko TM
    J Immunol; 2011 Apr; 186(7):3918-26. PubMed ID: 21368230
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IL-34 is a Treg-specific cytokine and mediates transplant tolerance.
    Bézie S; Picarda E; Ossart J; Tesson L; Usal C; Renaudin K; Anegon I; Guillonneau C
    J Clin Invest; 2015 Oct; 125(10):3952-64. PubMed ID: 26389674
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Foxp3+ regulatory T cells are activated in spite of B7-CD28 and CD40-CD40L blockade.
    Vogel I; Verbinnen B; Maes W; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2013 Apr; 43(4):1013-23. PubMed ID: 23348953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells.
    Delemarre EM; van den Broek T; Mijnheer G; Meerding J; Wehrens EJ; Olek S; Boes M; van Herwijnen MJ; Broere F; van Royen A; Wulffraat NM; Prakken BJ; Spierings E; van Wijk F
    Blood; 2016 Jan; 127(1):91-101. PubMed ID: 26480932
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
    Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
    Front Immunol; 2021; 12():786144. PubMed ID: 35095862
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Increased suppressor activity of transformed ex vivo regulatory T-cells in comparison with unstimulated cells of the same donor].
    Blinova VG; Gladilina YA; Eliseeva DD; Lobaeva TA; Zhdanov DD
    Biomed Khim; 2022 Jan; 68(1):55-67. PubMed ID: 35221297
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity.
    Zand MS; Bose A; Vo T; Coppage M; Pellegrin T; Arend L; Lee FE; Bozorgzadeh A; Leong N
    Am J Transplant; 2005 Jan; 5(1):76-86. PubMed ID: 15636614
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Very Low Numbers of CD4
    Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
    Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
    Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
    Jenabian MA; Patel M; Kema I; Vyboh K; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Gilmore N; Ancuta P; Tremblay C; Routy JP
    Clin Exp Immunol; 2014 Oct; 178(1):102-11. PubMed ID: 24924152
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.